Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0Y3JI
|
||||
Former ID |
DIB003176
|
||||
Drug Name |
DG-17
|
||||
Synonyms |
DG-35; Nar DG-35 Prodrug; DG-35-VIII
|
||||
Indication | Human immunodeficiency virus infection [ICD9: 279.3; ICD10:B20-B26] | Phase 2 | [550282] | ||
Company |
Narhex Life Sciences Ltd
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
n1c(C(=O)N[C@H](C(=O)N[C@H]([C@H](CN(NC(=O)OC(C)(C)C)C(<br />C)C)O)Cc2ccccc2)CC(=O)N)ccc2c1cccc2
|
||||
CAS Number |
CAS 155073-99-7
|
||||
Target and Pathway | |||||
Target(s) | HIV protease | Target Info | Inhibitor | [544059] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.